©2018 Technological and Data-Driven Innovations in Cancer Care.

SPECIAL SESSION

t4c.JPG
1200px-IEEE_logo.svg.png
bibe2019.jpg

Technological and Data-Driven Innovations in Cancer Care

BIBE 2019 Special Session

16:20-18:40

Connected Health as an enabler of Cancer Patient Support. 

Gabriel Signorelli


Cervical Cancer Diagnosis using CervixNet - A Deep Learning Approach.

Rohan Gorantla, Rajeev Kumar Singh, Rohan Pandey and Mayank Jain

 

Using Electronic Patient Reported Outcomes to Foster Palliative Cancer Care: the MyPal Approach.

Christos Maramis, Christina Karamanidou, Fatima Schera, Stephan Kiefer, Lefteris Koumakis, Konstantinos Marias, Stefan Hoffmann, Heather Parker, Jonathan Reston, Sheila Payne, Sarka Pospisilova, Richard Rosenquist, Paolo Ghia, Helen Papadaki, Annette Sander, Michael Doubek, Norbert Graf, Julie Ling, Julia Downing, Elpida Pavi and Vassilis Koutkias

 

Breast cancer heterogeneity investigation: multiple k-means clustering approach.

Joanna Tobiasz, Christos Hatzis and Joanna Polanska

 

OncoNetExplainer: Explainable Predictions of Cancer Types Based on Gene Expression Data.

Rezaul Karim, Michael Cochez, Oya Beyan, Stefan Decker, and Christoph Lange

 

Computational modeling of psychological resilience trajectories during breast cancer treatment.

Georgios Manikis, Konstantina Kourou, Paula Poikonen-Saksela, Haridimos Kondylakis, Evangelos Karademas, Kostas Marias, Dimitrios Katehakis, Lefteris Koumakis, Angelina Kouroubali, Ruth PatHorenczyk, Dimitrios Fotiadis, Manolis Tsiknakis and Panagiotis Simos

Automated Image Analysis Algorithms for Breast Cancer Decision Support.

Bryan Scotney, Philip Morrow, Hui Wang and Andrik Rampun

 

DESIREE DEMO - a web-based software ecosystem for the personalized, collaborative and multidisciplinary management of primary breast cancer. 

Nekane Larburu, Naiara Muroand Ivan Macia

THIS TRACK IS A COMBINED EFFORT FROM

4 EU FUNDED PROJECTS

catch.jpg

DESIREE PROJECT

DESIREE aims to provide a web-based software ecosystem for the personalized, collaborative and multidisciplinary management of Primary Breast Cancer by specialized Breast Units, from diagnosis to therapy and follow-up.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 690238

bounce.jpg

MyPal

MyPal is a Horizon 2020 (H2020) Research & Innovation Action (RIA) aiming to foster palliative care for people with cancer by leveraging patient reported outcome (PRO) systems through their adaptation to the personal needs of the person with cancer and his/her caregiver(s).

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement 

No 825872

CATCH ITN

CATCH ITN, which is an EU Horizon 2020-funded PhD training network, with academic and industry partners across Ireland, Spain and Denmark. The research within CATCH focuses on the development and use of technology to improve the quality of life of individuals living with and beyond cancer.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 
No. 722012

Desiree-LOGO-grande.png

BOUNCE PROJECT

BOUNCE proposes a holistic integrative and dynamic approach for investigating various heterogeneous but relevant biological, social, environmental, lifestyle, occupational, and socio-economic and psychosocial factors as they interact over time during the immediate cancer post-diagnosis period to account for individual fluctuations in resilience and eventually contribute to clinical outcomes and patient well-being.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 777167

mypal.JPG

Organizing Committee

Gabriel Signorelli

Marie-Curie Research Fellow and PhDresearcher at University College of Dublin, Ireland; Sports & Exercise Science Researcher at Oncoavanze, Seville, Spain.

With a master’s degree in Sports & Exercise Science, Gabriel worked in the fitness business for 10 years and was part of the developing and implementation team of BTFITapp, a Fitness App where his work was to specify the products and manage the user experience department. Gabriel is currently working on his PhD about how to improve Physical Activity Throughout Technologies in Cancer Patients to improve their Quality of Life.

Dr. Haridimos Kondylakis(M)
Collaborating Researcher at Computational BioMedicine Laboratory (CBML), Institute of Computer Science, Foundation of Research & Technology-Hellas (FORTH)

He received his PhD degree in Computer Science from the Univ. of Crete. His research interests span the following areas: Semantic Integration; Knowledge Evolution; Applications of Semantic Technologies to eHealth Systems; Big Data Management; Personal Health Systems. He has extensive experience in participating in more than 15 European Projects and was the co-PI in the iManageCancer project leading the technical development. He has more than 110 publications in premier international conferences, books and journals including ACM SIGMOD, VLDB, VLDBJ, JWS and KER. He has also served as a reviewer in several journals and conferences, such as JWS, JODS, CIKM, EDBT, ISWC and as a PC member in premier conferences and workshops.

gscholar.png
twitter_512.png
linkedin_416x416.jpg
linkedin_416x416.jpg
 

Committee members:

  • Marias Kostas: Ph.D., Associate Professor of Image Processing, Department of Informatics Engineering, Technological Educational Institute of Crete Head of Computational BioMedicine Laboratory at FORTH-ICS.

  • Ivan Macia: Director eHealth & Biomedical Applications (Vicomtech), Head of eHealth Group (Biodonostia), Coordinator DESIREE H2020.

  • Luis Fernandez Luque: Ph.D., eHealth Researcher, Qatar Computing Research Institute, HBKU, Doha Qatar; Co-founder and eHealth Advisor, Salumedia, Seville, Spain.

  • Prof. Roma Maguire: Professor of Digital Health and Care, University of Strathclyde, UK.

  • Louise Brennan: Marie-Curie Research Fellow and PhD researcher at University College of Dublin, Ireland, Research Physiotherapist at Beacon Hospital, Dublin.

  • Francisco M Monteiro-Guerra: PhD Researcher at University College of Dublin, Ireland; Research Fellow at Salumedia Tecnologías, Seville, Spain.

SPECIAL SESSION

The 19th annual IEEE International Conference on Bioinformatics and Bioengineering

IMPORTANT DATES

Paper Submission Deadline | July 15, 2019

Paper Acceptance Notification | August 10, 2019

Camera-Ready Paper Submission | August 30, 2019

Conference Date | October 28-30, 2019

calendar.jpg
1200px-IEEE_logo.svg.png
bibe2019.jpg

IEEE BIBE 2019

Athens, Greece | 28-30 October 2019

he 19th annual IEEE International Conference on BioInformatics and BioEngineering (IEEE BIBE 2019) will be held at the Royal Olympic hotel , which is a five-star hotel located in the center of Historical Athens. The hotel lays just in front of the famous Temple of Zeus and National Garden. Moreover, the hotel is just underneath the Acropolis and only 2 minutes walk to the new Acropolis Museum.

 
 

CALL FOR PAPERS!

Technological and Data-Driven Innovations in Cancer Care

BIBE 2019 Special Session

 

The worldwide incidence of cancer is gradually increasing, meanwhile the overall death rates from cancer continue to decline. These global trends have resulted in more people than ever living with or beyond cancer. As such, there is a greater necessity to improve and optimize cancer care services, throughout diagnosis, treatment, rehabilitation, and end-of-life care. Modern technologies, often enabled by the availability of big data and advanced analytics, have demonstrated potential to enhance the current quality of cancer care, for example by improving information access, informing clinical decision making and facilitating communications.

Pioneering research is now being conducted in the field of technology for cancer care, resulting in the development of novel solutions to a diverse spectrum of problems in this area. However, the process of evaluation of these innovations and how they operate within a ‘real-world’ context is at a less advanced stage. The clinical assessment of technology possesses many challenges and is influenced by numerous variables. As a result, there is an emphasis on the early evaluation of technology by including key stakeholders throughout its’ design and development.

Evidently, as researchers involved in the creation of novel technologies for cancer care, we must consider and share both the innovative concepts being developed, and also how they are being assessed and accepted in real-world or clinical situations. This track aims to address both these themes through six originals studies to be presented in the session.

This track is a combined effort from 4 EU funded projects:

CATCH ITN | DESIREE | BOUNCE | MyPal

 

This special track invites original research on innovative concepts, methods, tools and services that harness technology and big data to address challenges in the field of cancer care. Method of implementing these innovations in real-world settings will also be considered. Topics of interest include, but are not limited to:

  • Patient technologies for managing specific symptoms, impairments or conditions

  • Mobile self-management for people with cancer

  • Technologies supporting clinician-patient communication

  • Mobile technologies and social media

  • Biofeedback and rehabilitation technologies

  • Physical activity and lifestyle-change promotion using connected health

  • Privacy and security of digital personal health information

  • The use of social media by people with cancer

  • Multidisciplinary models and implementation research

All submissions in special sessions will be required to follow the 1-page abstract format and will not be included in the IEEE Xplore Conference Proceedings. However, authors interested in publishing their paper in the IEEE Xplore Conference Proceedings, may submit, in addition to their 1-page abstract, a 4-page paper, following the corresponding guidelines and deadline for full-length paper submission. Slightly different titles should be used for the two submissions.